Articles

Treatment of post-challenge glucose (PCG) levels may reduce cardiovascular disease and mortality associated with type 2 diabetes.

Results of the Heart Protection Study provide strong evidence for aggressively managing cardiovascular risk in type 2 diabetic patients.

Can treating AGEs lead to a reduction of endothelial dysfunction?

This information could save about 50,000 lives a year — that is, a thousand each week.”

New research shows that cardiovascular risks can increase even before patients develop diabetes.

Increasing daily aspirin use to 90% of those with Type 2 diabetes could prevent an additional 11,000 MIs and potentially save >8,000 lives.

An illuminating theory may lead to a simple way to prevent a common cause of blindness among diabetics.

There are distinct barriers and facilitators in managing patients with type 2 DM.

In studies they have found a special type of dendritic cell that kills the T cells and appears to prevent diabetes in mice.

Diabetes management will grow at an annual rate of 11 percent during the next decade, according to a market research report.